CLINICAL_TRIALS
research
· 2026-02-27
Clinical Trial Update: MetSense Pilot and Feasibility [NA]
Summary
MetSense pilot and feasibility trial is currently enrolling by invitation at Kaiser Permanente for serious mental illness and Type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Kaiser Permanente | Conditions: Serious Mental Illness, Type 2 Diabetes | NA | Status: ENROLLING_BY_INVITATION